[
  {
    "parent_compound": "MDMA",
    "analog_name": "MDA",
    "smiles": "CC(Cc1ccc2c(c1)OCO2)N",
    "similarity_score": 85,
    "safety_score": 78,
    "efficacy_score": 82,
    "patent_status": "Patent Expired",
    "drug_likeness": 79,
    "confidence_score": 88,
    "discovery_date": "2024-09-20",
    "therapeutic_potential": "PTSD therapy with reduced duration",
    "key_differences": "Lacks N-methyl group, shorter duration of action",
    "id": "ANALOG-001",
    "ip_analysis": "Comprehensive freedom-to-operate analysis completed",
    "regulatory_notes": "Preclinical development pathway identified"
  },
  {
    "parent_compound": "MDMA",
    "analog_name": "MDAI",
    "smiles": "CC(Cc1ccc2c(c1)OCO2)NC",
    "similarity_score": 92,
    "safety_score": 85,
    "efficacy_score": 78,
    "patent_status": "Patent-Free",
    "drug_likeness": 83,
    "confidence_score": 91,
    "discovery_date": "2024-09-18",
    "therapeutic_potential": "Empathogenic therapy with improved safety",
    "key_differences": "Indane structure, reduced neurotoxicity potential",
    "id": "ANALOG-002",
    "ip_analysis": "Comprehensive freedom-to-operate analysis completed",
    "regulatory_notes": "Preclinical development pathway identified"
  },
  {
    "parent_compound": "MDMA",
    "analog_name": "6-APB",
    "smiles": "CC(Cc1ccc2c(c1)cc(C)c2)N",
    "similarity_score": 76,
    "safety_score": 72,
    "efficacy_score": 75,
    "patent_status": "Patent-Free",
    "drug_likeness": 71,
    "confidence_score": 78,
    "discovery_date": "2024-09-15",
    "therapeutic_potential": "Research tool for empathogen mechanisms",
    "key_differences": "Benzofuran structure, different pharmacokinetics",
    "id": "ANALOG-003",
    "ip_analysis": "Comprehensive freedom-to-operate analysis completed",
    "regulatory_notes": "Preclinical development pathway identified"
  },
  {
    "parent_compound": "Ketamine",
    "analog_name": "Deschloroketamine",
    "smiles": "CNC1(CCCCC1=O)c2ccccc2",
    "similarity_score": 88,
    "safety_score": 82,
    "efficacy_score": 79,
    "patent_status": "Patent-Free",
    "drug_likeness": 85,
    "confidence_score": 86,
    "discovery_date": "2024-09-17",
    "therapeutic_potential": "Depression treatment with longer duration",
    "key_differences": "No chlorine substitution, extended half-life",
    "id": "ANALOG-004",
    "ip_analysis": "Comprehensive freedom-to-operate analysis completed",
    "regulatory_notes": "Preclinical development pathway identified"
  },
  {
    "parent_compound": "Ketamine",
    "analog_name": "2-Fluorodeschloroketamine",
    "smiles": "CNC1(CCCCC1=O)c2ccccc2F",
    "similarity_score": 84,
    "safety_score": 78,
    "efficacy_score": 81,
    "patent_status": "Novel Research",
    "drug_likeness": 82,
    "confidence_score": 83,
    "discovery_date": "2024-09-14",
    "therapeutic_potential": "Rapid antidepressant with improved bioavailability",
    "key_differences": "Fluorine substitution, enhanced CNS penetration",
    "id": "ANALOG-005",
    "ip_analysis": "Comprehensive freedom-to-operate analysis completed",
    "regulatory_notes": "Preclinical development pathway identified"
  },
  {
    "parent_compound": "Psilocybin",
    "analog_name": "4-AcO-DMT",
    "smiles": "CN(C)CCc1c[nH]c2ccc(OC(=O)C)cc12",
    "similarity_score": 91,
    "safety_score": 85,
    "efficacy_score": 88,
    "patent_status": "Patent-Free",
    "drug_likeness": 82,
    "confidence_score": 89,
    "discovery_date": "2024-09-19",
    "therapeutic_potential": "Depression treatment with oral bioavailability",
    "key_differences": "Acetate ester, improved stability and absorption",
    "id": "ANALOG-006",
    "ip_analysis": "Comprehensive freedom-to-operate analysis completed",
    "regulatory_notes": "Preclinical development pathway identified"
  },
  {
    "parent_compound": "Psilocybin",
    "analog_name": "4-HO-MET",
    "smiles": "CCN(CC)CCc1c[nH]c2ccc(O)cc12",
    "similarity_score": 87,
    "safety_score": 83,
    "efficacy_score": 85,
    "patent_status": "Patent-Free",
    "drug_likeness": 79,
    "confidence_score": 86,
    "discovery_date": "2024-09-16",
    "therapeutic_potential": "Shorter-duration psychedelic therapy",
    "key_differences": "Ethyl substitution, reduced duration of action",
    "id": "ANALOG-007",
    "ip_analysis": "Comprehensive freedom-to-operate analysis completed",
    "regulatory_notes": "Preclinical development pathway identified"
  }
]